AKT1 and non-small cell lung carcinoma: That we demonstrate Thr308 phosphorylation to be a better marker for Akt activity than Ser473 phosphorylation could help to explain why Tsurutani et al (2006) found that Thr308 phosphorylation was a better predictor than Ser473 phosphorylation for poor overall survival in NSCLC.